Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,133 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06451458Enrolling by invitation
ECHO diabetes and chronic conditions training for care teams
This trial tests a program (ECHO) to help healthcare teams at busy clinics better support patients with diabetes and other ongoing health conditions. It focuses on training staff, not on giving you a new treatment.
Santa Fe, New MexicoAges 18–89 - NCT06452654RecruitingPhase 4
Vaccine to prevent type 1 diabetes in high-risk babies
This study tests whether a vaccine given to very young babies (3–4 months old) can prevent type 1 diabetes. It is designed for babies who have a high genetic risk and a family history of the disease.
ViennaAges 3 months–4 months - NCT06453928Recruiting
Starting diabetes technology for type 1 diabetes
This study helps people with type 1 diabetes who use insulin injections learn about and start using diabetes technology like continuous glucose monitors or insulin pumps. It aims to see if starting technology improves blood sugar control.
Santa Monica, CaliforniaAges 18 years+ - NCT07625020Recruiting
Nerve Hydrodissection for Diabetic Nerve Entrapment Pain
This trial tests a minimally invasive ultrasound-guided procedure that uses fluid injection to free trapped nerves in the lower legs of people with diabetes. The goal is to relieve pain, numbness, and weakness when standard medications haven't worked well enough.
Chongqing, Chongqing MunicipalityAges 18–85 - NCT06427421Recruiting
Immune cells in children with recent type 1 diabetes
This study looks at immune cells in children who were recently diagnosed with type 1 diabetes. It involves one extra blood draw to better understand how the immune system attacks the pancreas. If you join, no new treatments are given—just observation and analysis of your child's immune cells.
ParisAges 6–18 - NCT06426953Recruiting
Proteins in blood to predict confusion after surgery in older diabetics
This study looks at proteins in your blood (TGF-β and INS-PI3K-AKT) to see if they can predict confusion after surgery (postoperative delirium) in older adults with diabetes. It may help doctors identify who is at higher risk.
Duyun, GuizhouAges 65 years+ - NCT06435156RecruitingPhase 2
Sotagliflozin for Heart Failure in Type 1 Diabetes
This trial tests a medication called sotagliflozin for people who have both type 1 diabetes and heart failure symptoms. The goal is to see if it can improve how you feel and manage your heart and diabetes.
AberdeenAges 18–84 - NCT06420661Enrolling by invitation
School program for children with type 1 diabetes
This study tests a special program called SPACE that helps children with type 1 diabetes by working together with their school nurse and diabetes team. The goal is to improve diabetes care and support at school.
Pittsburgh, PennsylvaniaAges 5–12 - NCT06426277Recruiting
Brazilian diabetes prevention program
This study tests a program that helps people with prediabetes make healthy lifestyle changes to prevent type 2 diabetes. You would get support through your own device at home, with no need for in-person visits.
Goiânia, GoiásAges 18 years+ - NCT06437028Recruiting
Membrane allograft for diabetic foot ulcers
This trial tests a special membrane made from donated birth tissue (perinatal membrane) placed on a diabetic foot ulcer to help it heal faster. It's for people with diabetes whose foot ulcer hasn't healed after standard care for 4 weeks to a year.
Monroe, North CarolinaAges 18 years+ - NCT06415643Recruiting
Lab-grown islet cells for diabetes after pancreas surgery
This trial tests whether lab-grown islet cells (pancreatic organoids) can help control blood sugar in people who develop diabetes after having most or all of their pancreas removed. If successful, this could reduce the need for insulin shots.
Hangzhou, ZhejiangAges 18–70 - NCT06411210RecruitingPhase 2
Weight loss medication for young adults with type 1 diabetes
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
New Haven, ConnecticutAges 18–30 - NCT06412224RecruitingEarly Phase 1
Testing a new drug for diabetic eye disease after vitrectomy
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
TianjinAges 20–80 - NCT06419777Recruiting
When to start diabetes medicine in pregnancy
This study compares two ways of starting diabetes medication during pregnancy for women with gestational diabetes. It will test whether starting medication earlier or later helps control blood sugar and leads to better outcomes for you and your baby.
Rochester, New YorkAges 18 years+ - NCT06419803Recruiting
When to start medication for gestational diabetes
This study compares two different blood sugar targets to decide when to start medication for gestational diabetes. It aims to find the safest approach for you and your baby.
Rochester, New YorkAges 18 years+ - NCT06408207Recruiting
CGM Academy for Youth with Type 1 Diabetes
This study tests a program to help young people with type 1 diabetes learn to use continuous glucose monitors (CGMs) like Dexcom G6 and G7. It aims to improve diabetes management through education and support.
Los Angeles, CaliforniaAges 8–18 - NCT07657286Recruiting
Exercise and inflammation in diabetic kidney disease
This trial tests whether exercise can help people with diabetes and chronic kidney disease by reducing inflammation and stress in the body. It may show if a workout program can improve overall health.
CairoAges 36–58 - NCT06384313Recruiting
Butyrate supplement for preventing diabetes
This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.
Maastricht, LimburgAges 20–70 - NCT06384911Recruiting
Helping Teens Invest in Diabetes Care
This study tests whether offering small rewards and education can help teenagers with type 1 diabetes check their blood sugar more often and give themselves more insulin before meals. It's designed for teens who are having trouble using their CGM or giving enough insulin.
Seattle, WashingtonAges 12 years+ - NCT07625007Recruiting
Shortwave Therapy for Diabetic Nerve Pain
This trial tests a shortwave treatment to relieve pain and other nerve symptoms in people with diabetic peripheral neuropathy (nerve damage from diabetes). It is for adults who have not found enough relief from standard nerve medications.
ChongqingAges 18–85 - NCT06375460Recruiting
Using real-time glucose feedback to manage type 2 diabetes
This study tests a new program that uses real-time feedback from a continuous glucose monitor (a small sensor that checks your blood sugar) to help you learn how to manage your type 2 diabetes better. It could help you understand how your daily choices affect your blood sugar and improve your control.
Pittsburgh, PennsylvaniaAges 14–26 - NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Madrid, MadridAges 50–75 - NCT06343974Recruiting
Ultrasound to detect high insulin in unborn babies
This study uses ultrasound images to check for high insulin levels in unborn babies. It may help doctors detect problems early and improve care for moms and babies.
TurkuAges 18–45 - NCT06345118Recruiting
Fall prevention for older adults with type 2 diabetes
This trial studies a fall prevention program for older adults with type 2 diabetes. The goal is to see if it reduces falls and improves safety.
HanoiAges 60–60
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,133 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.